nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry
|
Adachi, Yayoi |
|
|
201 |
3 |
p. 397-408 |
artikel |
2 |
Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases
|
Chen, Bo-Fang |
|
|
201 |
3 |
p. 547-560 |
artikel |
3 |
Differential distribution of actual and surrogate oncotype DX recurrence scores in breast cancer patients by age, menopausal status, race, and body mass index
|
Mohamed, Anas |
|
|
201 |
3 |
p. 447-460 |
artikel |
4 |
Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers
|
Sharma, Tanu |
|
|
201 |
3 |
p. 561-570 |
artikel |
5 |
Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC–MS/MS (liquid chromatography–tandem mass spectrometry) method for estrogen measurement
|
Faltinová, Mária |
|
|
201 |
3 |
p. 425-435 |
artikel |
6 |
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer
|
Chen, Chen |
|
|
201 |
3 |
p. 515-533 |
artikel |
7 |
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy
|
Chaudhary, Lubna N. |
|
|
201 |
3 |
p. 387-396 |
artikel |
8 |
Is de-escalation of treatment by omission of radiotherapy associated with fear of cancer recurrence in women with early breast cancer? An exploratory study
|
Stafford, Lesley |
|
|
201 |
3 |
p. 367-376 |
artikel |
9 |
Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system
|
Knerr, Sarah |
|
|
201 |
3 |
p. 461-470 |
artikel |
10 |
Oestrogen receptor low positive breast cancer: associations with prognosis
|
Skjervold, Anette H. |
|
|
201 |
3 |
p. 535-545 |
artikel |
11 |
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03)
|
Kobayashi, Kokoro |
|
|
201 |
3 |
p. 409-415 |
artikel |
12 |
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients
|
Muendlein, Axel |
|
|
201 |
3 |
p. 571-576 |
artikel |
13 |
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer
|
Chen, Tom Wei-Wu |
|
|
201 |
3 |
p. 377-385 |
artikel |
14 |
Prediction of nipple involvement in breast cancer after neoadjuvant chemotherapy: Should we rely on breast MRI to preserve the nipple?
|
Ugurlu, M. Umit |
|
|
201 |
3 |
p. 417-424 |
artikel |
15 |
Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study
|
Smedsland, Solveig K. |
|
|
201 |
3 |
p. 479-488 |
artikel |
16 |
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast
|
Tsunokake, Satoko |
|
|
201 |
3 |
p. 499-513 |
artikel |
17 |
The dynamics of HER2-low expression during breast cancer progression
|
Anderson, Sarah |
|
|
201 |
3 |
p. 437-446 |
artikel |
18 |
The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
|
Waaijer, M. E.C. |
|
|
201 |
3 |
p. 471-478 |
artikel |
19 |
The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4
|
Chen, Wenhu |
|
|
201 |
3 |
p. 353-366 |
artikel |
20 |
Treatments for breast cancer in men: late effects and impact on quality of life
|
Avila, Jorge |
|
|
201 |
3 |
p. 489-498 |
artikel |